SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: paul goldstein who wrote (417)9/7/1996 1:15:00 PM
From: Richard Mazzarella   of 4342
 
All, more interesting reading: critpath.org

Paul, The EMIS lesson is a good one. EMIS has great ideas on oral drugs, but the drug manufactures don't care how it's administered. It's not their arm or leg that has to get punctured daily. They make money however the drug is given. This thread's comments about the difficulty of getting the majors on board is a good one. The biggies have their HIV drugs. They really don't care if someone has a better system because it's only the money that moves them. The only thing that can change that is if it becomes clear that PRLN will deliver superior therapy and displace them. PRLN will probably have to posture itself to sell its drugs which could put the others out of business before anything serious will occur with partnerships. The more we walk this logic through, the better feeling I am getting for the difficulty of PRLN becoming successful.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News